Eurican DAP-Lmulti inj. susp. (lyoph. + susp.) s.c. vial

Land: Belgien

Sprache: Englisch

Quelle: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Wirkstoff:

Leptospira Kirschneri Serovar Gryppotyphosa (Inactivated) ; Canine Distemper Virus (live, attenuated) ; Leptospira Interrogans Serogroup Icterohaemorrhagiae (Inactivated) ; Canine Parvovirus (live, attenuated) ; Leptospira Interrogans Serogroup Canicola (Inactivated) ; Canine Adenovirus 2 (live, attenuated)

Verfügbar ab:

Boehringer Ingelheim Animal Health Belgium SA-NV

ATC-Code:

QI07AI03

INN (Internationale Bezeichnung):

Leptospira Interrogans Canicola; Leptospira Interrogans Icterohaemorrhagiae; Leptospira Interrogans Grippotyphosa; Canine Distemper Virus (CDV); Canine Adenovirus Type 2; Canine Parvovirus Type 2

Darreichungsform:

Lyophilisate and suspension for suspension for injection

Zusammensetzung:

Leptospira Interrogans Canicola; Leptospira Interrogans Icterohaemorrhagiae; Leptospira Interrogans Grippotyphosa; Canine Distemper Virus (CDV); Canine Adenovirus Type 2; Canine Parvovirus Type 2

Verabreichungsweg:

Subcutaneous use

Therapiegruppe:

dog

Therapiebereich:

Live Canine Distemper Virus + Live Canine Adenovirus + Live Canine Parvovirus + Inactivated Leptospira

Produktbesonderheiten:

CTI code: 480346-01 - Pack size: 10 x 1 dose + 10 x 1 ml - Commercialisation status: YES - CNK code: 3424389 - Delivery mode: Medical prescription; CTI code: 480346-02 - Pack size: 25 x 1 dose + 25 x 1 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 480346-03 - Pack size: 50 x 1 dose + 50 x 1 ml - Commercialisation status: NO - Delivery mode: Medical prescription

Berechtigungsstatus:

Commercialised: Yes

Berechtigungsdatum:

2015-10-22